secwatch.observer — SEC 8-K summary
======================================

Issuer:     MeiraGTx Holdings plc (MGTX)
CIK:        0001735438
Form:       8-K
Filed at:   2025-03-13T23:59:59+00:00
Accession:  0001558370-25-002859
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MeiraGTx enters collaboration with Hologen AI: $200M upfront, $230M JV funding for AAV-GAD
--------------------------------------------------------------------------------

- Received $200M upfront cash from Hologen; forming JV Hologen Neuro AI Ltd.
- Hologen commits up to $230M additional capital to JV to fund AAV-GAD Parkinson's development.
- MeiraGTx retains 30% ownership in JV, leads clinical development and manufacturing.
- Hologen takes minority stake in MeiraGTx's manufacturing subsidiary; AI optimization.
- Closing expected Q2 2025, subject to UK FDI regulatory approvals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1735438/000155837025002859/0001558370-25-002859-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1735438/000155837025002859/mgtx-20250309x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-002859

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer